Regulations.gov document
Questions and Answers on BiosimilarDevelopment and the Biologics Price Competition and…
Notice · FDA-2011-D-0611 · posted Sep 20, 2021
Key facts
| Document ID | FDA-2011-D-0611-0088 |
|---|---|
| Title | Questions and Answers on BiosimilarDevelopment and the Biologics Price Competition and Innovation Act of 2009; Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2011-D-0611 |
| Posted | Sep 20, 2021 |
| Federal Register citation | 86 FR 52154 |
| FR document number | 2021-20255 |
| Comment period opens | Sep 20, 2021 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: